EUVIMEDEUVIMED entdecken
Open Access

Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access

Ann Oluloro iD, Elizabeth M Swisher iD, Heidi J Gray, Barbara Goff iD, Kemi M Doll iD

JNCI: Journal of the National Cancer Institute · 2025

DOI: 10.1093/jnci/djae338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Ann Oluloro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195, United States. Hauptthemen laut MEDLINE: Patient Selection, Clinical Trials as Topic, Genital Neoplasms, Female, Eligibility Determination. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institute of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Racial and ethnic minorities remain underrepresented in gynecologic cancer clinical trials despite disproportionately worse oncologic outcomes. Research shows differential racial enrollment patterns because of comorbidity-based exclusion criteria. Our objective was to evaluate contemporary trends in comorbidity-based exclusion criteria among National Cancer Institute–sponsored gynecologic cancer clinical trials and protocol adherence to broadened eligibility criteria guidelines as an assessment of equitable enrollment access.

Methods

The ClinicalTrials.gov registry was queried for National Cancer Institute–sponsored gynecologic cancer clinical trials (1994-2021). Study characteristics and comorbidity-based exclusion criteria were abstracted from protocols. Descriptive statistics and temporal trends were calculated using χ2 testing with STATA v17 software.

Results

Among 279 clinical trials identified, 65% completed enrollment, 53% were phase II, and 48% focused on ovarian cancer. Pharmaceutical agents (85%) were the primary therapeutic interventions. Several inequitably restrictive exclusion criteria increased over time such as hepatitis infection (17% in 1994-2000 vs 49% in 2015-2021, P < .001) and cardiovascular disease (47% in 1994-2000 vs 66% in 2015-2021, P = .002). A previously rare exclusion, “mental illness and/or social situations,” dramatically increased from 5% to 51% (P < .001) over 3 decades. Adherence to broadened eligibility criteria recommendations was mixed. Renal function, cardiovascular disease, and performance status criteria were not broadened, but HIV, prior or concurrent malignancies, and brain metastasis criteria were.

Conclusions

Some, but not all, of the known restrictive comorbidity-based exclusion criteria have increased in gynecologic cancer clinical trial design, despite calls for improving racial and ethnic minority representation. Exclusion criteria are critical for trial safety, however, they must be carefully considered given the differential racial impact on eligibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient SelectionClinical Trials as TopicGenital Neoplasms, FemaleEligibility DeterminationHealthcare DisparitiesHumansFemaleUnited StatesRegistriesComorbidity

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Washington, Seattle, WA 98195, United States.

ORCID-Profile: Ann Oluloro, Elizabeth M Swisher, Barbara Goff, Kemi M Doll

Förderung

  • NCI NIH HHS
  • National Institute of Health
  • National Cancer Institute

Zitieren

APA

Oluloro, A., Swisher, E. M., Gray, H. J., Goff, B., & Doll, K. M. (2025). Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae338

Vancouver

Oluloro A, Swisher EM, Gray HJ, Goff B, Doll KM. Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djae338

BibTeX
@article{Oluloro2025,
  author = {Oluloro, Ann and Swisher, Elizabeth M and Gray, Heidi J and Goff, Barbara and Doll, Kemi M},
  title = {Gynecologic cancer clinical trial eligibility criteria as a marker for equitable clinical trial access},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2025},
  doi = {10.1093/jnci/djae338}
}
Kostenlos starten →